James Catto

Dec 19, 2024 | ejso.com | Simone Albisinni |Luca Orecchia |Georges Mjaess |Fouad Aoun |Francesco Del Giudice |Luca Antonelli | +10 more

Review ArticleArticles in Press109543 1Urology Unit, Department of Surgical Sciences, Tor Vergata University Hospital, University of Rome Tor Vergata, Rome, Italy 2Department of Urology, Hopital Universitaire de Bruxelles, Universite’ Libre de Bruxelles, Bruxelles, Belgium 3Faculty of Medicine, Hôtel-Dieu de France, Saint-Joseph University, Beirut, Lebanon 4Department of Urology, Policlinico Umberto I, Sapienza University, Rome, Italy 5Department of Urology, Kantonsspital Luzern, Lucerne,...

Sep 30, 2024 | europeanurology.com | Roger Li |Joshua A. Linscott |James Catto |Joshua J. Meeks |Siamak Daneshmand |Bishoy M Faltas | +4 more

Property Value Status Version Ad File Disable Ads Flag Environment Moat Init Moat Ready Contextual Ready Contextual URL Contextual Initial Segments Contextual Used Segments AdUnit SubAdUnit Custom Targeting Ad Events Invalid Ad Sizes aDepartment of Genitourinary Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USAbDepartment of Immunology, H.

Oct 27, 2023 | onclive.com | James Catto

James Catto, MB, ChB, PhD, FRCS, professor, urological surgery, clinical medicine, NIHR Research Professor, School of Medicine and Population Health, University of Sheffield, honorary consultant urological surgeon, Sheffield Teaching Hospitals, NHS Trust, honorary senior clinical research fellow, the University of Oxford, honorary clinical professor, Division of Surgery and Interventional Science, University College London, discusses the utility of erdafitinib (Balversa) in patients with...